Prenatal treatment of congenital adrenal hyperplasia: Risks outweigh benefits

American Journal of Obstetrics and Gynecology

Volumn 208, Issue 5, 2013, Pages 354-359

  Miller, Walter L ^a   Witchel, Selma Feldman ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

adrenal hyperplasia; congenital adrenal hyperplasia; dexamethasone; fetus; prenatal treatment

Indexed keywords

DEXAMETHASONE;

ANXIETY; ARTICLE; BIRTH WEIGHT; BRAIN DEVELOPMENT; CONGENITAL ADRENAL HYPERPLASIA; DNA METHYLATION; DRUG EFFICACY; GENETIC SCREENING; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MEDICAL ETHICS; MISSENSE MUTATION; NONHUMAN; PANCREAS ISLET BETA CELL; PRENATAL CARE; PRIORITY JOURNAL; VIRILIZATION; WORKING MEMORY;

ADRENAL HYPERPLASIA, CONGENITAL; ANIMALS; DEXAMETHASONE; FEMALE; FETAL THERAPIES; GLUCOCORTICOIDS; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84876695205     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.10.885     Document Type: Article

References (56)

1. P.W. Speiser, R. Azziz, L.S. Baskin Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 95 2010 4133 4160
2. M.G. Forest, Y. Morel, M. David Prenatal treatment of congenital adrenal hyperplasia Trends Endocrinol Metab 9 1998 284 289
3. M.I. New, A. Carlson, J. Obeid Extensive personal experience: prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies J Clin Endocrinol Metab 86 2001 5651 5657
4. W.L. Miller, R.J. Auchus The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders Endocr Rev 32 2011 81 151
5. S.F. Witchel, R. Azziz Congenital adrenal hyperplasia J Pediatr Adolesc Gynecol 24 2011 116 126
6. L.H. Braga, J.L. Pippi Salle Congenital adrenal hyperplasia: a critical appraisal of the evolution of feminizing genitoplasty and the controversies surrounding gender reassignment Eur J Pediatr Surg 19 2009 203 210
7. A. Nordenskjöld, G. Holmdahl, L. Frisén Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia J Clin Endocrinol Metab 93 2008 380 386
8. P.C. White, P.W. Speiser Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Endocr Rev 21 2000 245 291
9. B.L. Linder, N.V. Esteban, A.L. Yergey, J.C. Winterer, D.L. Loriaux, F. Cassorla Cortisol production rate in childhood and adolescence J Pediatr 117 1990 892 896
10. N.V. Esteban, T. Loughlin, A.L. Yergey Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry J Clin Endocrinol Metab 72 1991 39 45
11. J.R. Kerrigan, J.D. Veldhuis, S.A. Leyo, H.A. Iranmanes, A.D. Rogol Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis J Clin Endocrinol Metab 76 1993 1505 1510
12. D.M. Styne, G.E. Richards, J.J. Bell Growth patterns in congenital adrenal hyperplasia-correlation of glucocorticoid therapy with stature P. Lee, L. Plotnick, A. Kowarski, C. Migeon, Congenital adrenal hyperplasia 1977 University Park Press Baltimore 247 261
13. S.A. Rivkees, J.D. Crawford Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth Pediatrics 106 2000 767 773
14. C.J. Partsch, W.G. Sippell, I.Z. MacKenzie, A. Aynsley-Green The steroid hormonal milieu of the undisturbed human fetus and mother at 16-20 weeks gestation J Clin Endocrinol Metab 73 1991 969 974
15. M.A. Kari, K.O. Raivio, U.-H. Stenman, R. Voutilainen Serum cortisol, dehydroepiandrosterone sulfate, and sterol-binding globulins in preterm neonates: effects of gestational age and dexamethasone therapy Pediatr Res 40 1996 319 324
16. M.G. Forest Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency Hum Reprod Update 10 2004 469 485
17. S. Lajic, A. Wedell, T.-H. Bui, E.M. Ritzen, M. Holst Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia J Clin Endocrinol Metab 83 1998 3872 3880
18. J.M. Rowland, A.G. Hendrickx Corticosteroid teratogenicity Adv Vet Sci Comp Med 27 1983 99 128
19. M.K. Ziejewski, H.M. Solomon, D. Stanislaus, R.L. Clark, T.E. White, A.R. Apostoli The potential role for corticosterone in the induction of cleft palate in mice after treatment with a selective NK-1 receptor antagonist, casopitant (GW679769B) Birth Defect Res (Part B) 95 2012 54 62
20. G. Celsi, A. Kistner, R. Aizman Prenatal dexamethasone causes oligonephria, sodium retention, and higher blood pressure in the offspring Pediatr Res 4 1998 317 322
21. H. Dickinson, D.W. Walker, E.M. Wintour, K. Moritz Maternal dexamethasone treatment at midgestation reduces nephron number and alters renal gene expression in the fetal spiny mouse Am J Physiol Regul Integr Comp Physiol 292 2007 R453 R461
22. M.J. Nyirenda, R.S. Lindsay, C.J. Kenyon, A. Burchell, J.R. Seckl Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring J Clin Invest 101 1998 2174 2181
23. M. Iqbal, V.G. Moisiadis, A. Kostaki, S.G. Matthews Transgenerational effects of prenatal synthetic glucocorticoids on hypothalamic-pituitary-adrenal function Endocrinology 153 2012 3295 3307
24. A. de Vries, M.C. Holmes, A. Heijnis Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function J Clin Invest 117 2007 1058 1067
25. R.S. Lindsay, R.M. Lindsay, C.R. Edwards, J.R. Seckl Inhibition of 11β-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring Hypertension 27 1996 1200 1204
26. R.S. Lindsay, R.M. Lindsay, B.J. Waddell, J.R. Seckl Prenatal glucocorticoid exposure leads to offspring hyperglycemia in the rat: studies with the 11β-hydroxysteroid dehydrogenase inhibitor carbenoxolone Diabetologia 39 1996 1299 1305
27. M.C. Holmes, C.T. Abrahamsen, K.L. French, J.M. Paterson, J.J. Mullins, J.R. Seckl The mother or the fetus? 11β-Hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids J Neurosci 26 2006 3840 3844
28. S.G. Mathews Antenatal glucocorticoids and the developing brain: mechanisms of action Semin Neonatol 6 2001 309 317
29. D.M. Sloboda, J.R.G. Challis, T.J.M. Moss, J.P. Newnham Synthetic glucocorticoids: antenatal administration and long-term implications Curr Pharm Des 11 2005 1459 1472
30. W.L. Huang, L.D. Beazley, J.A. Quinlivan, S.F. Evans, J.P. Newnham, S.A. Dunlop Effect of corticosteroids on brain growth in fetal sheep Obstet Gynecol 94 1999 213 218
31. T.J.M. Moss, D.A. Doherty, I. Nitsos, D.M. Sloboda, R. Harding, J.P. Newnham Effects into adulthood of single or repeated antenatal corticosteroids in sheep Am J Obstet Gynecol 192 2005 146 152
32. J.A. Quinlivan, S.A. Dunlop, J.P. Newnham, S.F. Evans, L.D. Beazley Repeated, but not single, maternal administration of corticosteroids delays myelination in the brain of fetal sheep Perinat Neonatal Med 4 1999 47 55
33. H. Uno, L. Lohmiller, C. Thieme Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques, I: hippocampus Dev Brain Res 53 1990 157 167
34. US Dept of Health and Human Services Website on chemical hazards emergency medical management. National Instutites of Health, 2011 http://chemm.nlm.nih.gov/pregnancycategories.htm Accessed Nov. 6, 2012
35. S.L. Carmichael, G.M. Shaw, C. Ma, M.M. Werler, S.A. Rasmussen, E.J. Lammer National Birth Defects Prevention Study Maternal corticosteroid use and orofacial clefts Am J Obstet Gynecol 197 2007 585.e1 585.e7
36. M.G. Forest, M. David, Y. Morel Prenatal diagnosis and treatment of 21-hydroxylase deficiency J Steroid Biochem Mol Biol 45 1993 75 82
37. A.B. Mercado, R.C. Wilson, K.C. Cheng, J.Q. Wei, M.I. New Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency J Clin Endocrinol Metab 80 1995 2014 2020
38. X. Wang, B. Zuckerman, C. Pearson Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight JAMA 287 2002 195 202
39. A. Harris, J. Seckl Glucocorticoids, prenatal stress and the programming of disease Horm Behav 59 2011 279 289
40. D.J.P. Barker In utero programming of chronic disease Clin Sci 95 1998 115 128
41. B.A. Kelly, A.J. Lewandowski, S.A. Worton Antenatal glucocorticoid exposure and long-term alterations in aortic function and glucose metabolism Pediatrics 129 2012 e1282 e1290
42. J.R. Seckl, W.L. Miller How safe is long-term prenatal glucocorticoid treatment? JAMA 277 1997 1077 1079
43. J.R. Seckl Prenatal glucocorticoids and long-term programming Eur J Endocrinol 151 2004 U49 U62
44. H.F.L. Meyer-Bahlburg, C. Dolezal, S.W. Baker, A.D. Carlson, J.S. Obeid, M.I. New Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone J Clin Endocrinol Metab 89 2004 610 614
45. T. Hirvikoski, A. Nordenstrom, T. Lindholm Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone J Clin Endocrinol Metab 92 2007 542 548
46. T. Hirvikoski, A. Nordenstrom, F. Lindholm, E.M. Ritzén, S. Lajic Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioral problems? Eur J Endocrinol 159 2008 309 316
47. T. Hirvikoski, T. Lindholm, S. Lajic, A. Nordenström Gender role behavior in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia-a pilot study Acta Paediatr 100 2011 E112 E119
48. R.A. Samarasinghe, R. Di Maio, D. Volonte Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation Proc Natl Acad Sci U S A 108 2011 16657 16662
49. S. Dave-Sharma, R.C. Wilson, M.D. Harbison Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess J Clin Endocrinol Metab 83 1998 2244 2254
50. K. Räikkönen, A.K. Pesonen, K. Heinonen Maternal licorice consumption and detrimental cognitive and psychiatric outcomes in children Am J Epidemiol 170 2009 1137 1146
51. M. Poulain, N. Frydman, C. Duquenne Dexamethasone induces germ cell apoptosis in the human fetal ovary J Clin Endocrinol Metab 97 2012 E1890 E1897
52. J. Frias, L.S. Levine, S.E. Oberfield Technical report: congenital adrenal hyperplasia Pediatrics 106 2000 1511 1518
53. P.E. Clayton, W.L. Miller, S.E. Oberfield, E.M. Ritzen, W.G. Sippell, P.W. Speiser Joint LWPES/ESPE CAH Working Group (Writing Committee Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology J Clin Endocrinol Metab 87 2002 4048 4053
54. P.E. Clayton, W.L. Miller, S.E. Oberfield, E.M. Ritzen, W.G. Sippell, P.W. Speiser Joint ESPE/LWPES Working Group (Writing Committee Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society Hormone Res 58 2002 188 195
55. T. Hirvikoski, A. Nordenstrom, A. Wedell, M. Ritzen, S. Lajic Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint J Clin Endocrinol Metab 97 2012 1881 1883
56. S.F. Witchel, W.L. Miller Prenatal treatment of congenital adrenal hyperplasia-not standard of care J Genet Couns 21 2012 615 624